Circular RNA circSPATA6 Inhibits the Progression of Oral Squamous Cell Carcinoma Cells by Regulating TRAF6 via miR-182

References

• Jayaraj R, Kumarasamy C, Madurantakam Royam M, Devi A, Baxi S. Letter to the editor: is HIF-1α a viable prognostic indicator in OSCC? A critical review of a meta-analysis study. World J Surg Oncol. 2018;16(1):111. doi:10.1186/s12957-018-1408-429914529
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD. Cancer Statistics, 2019. CA. 2019;69(1):7–34.30620402
   PubMedGoogle Scholar
• Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM. Cancer treatment and survivorship statistics, 2019. Cancer J Clin. 2019;69(5):363–385. doi:10.3322/caac.21565
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB. The biogenesis, biology and characterization of circular RNAs. Int J Med. 2019;20(11):675–691.
   Google Scholar
• Li X, Yang L, Chen LL, Biogenesis T. Functions, and Challenges of Circular RNAs. Mol Cell. 2018;71(3):428–442.30057200
   PubMed Web of Science ®Google Scholar
• Zhang HD, Jiang LH, Sun DW, Hou JC, Ji ZL. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25(1):1–7.28721656
   PubMed Web of Science ®Google Scholar
• Xia L, Song M, Sun M, Wang F, Yang C. Circular RNAs as Biomarkers for Cancer. Adv Exp Med Biol. 2018;1087:171–187.30259366
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981–984.26138677
   PubMed Web of Science ®Google Scholar
• Li T, Shao Y, Fu L, et al. Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection. J Mol Med (Berl). 2018;96(1):85–96.29098316
   PubMed Web of Science ®Google Scholar
• Liang G, Yang Y, Niu G, Tang Z, Li K. Genome-wide profiling of Sus scrofa circular RNAs across nine organs and three developmental stages. DNA Res. 2017;24(5):523–535. doi:10.1093/dnares/dsx02228575165
   PubMed Web of Science ®Google Scholar
• Ouyang SB, Wang J, Zhao SY, Zhang XH, Liao L. CircRNA_0109291 regulates cell growth and migration in oral squamous cell carcinoma and its clinical significance. Iran J Basic Med Sci. 2018;21(11):1186–1191. doi:10.22038/IJBMS.2018.30347.731330483394
   PubMed Web of Science ®Google Scholar
• Gao L, Zhao C, Li S, et al. circ-PKD2 inhibits carcinogenesis via the miR-204-3p/APC2 axis in oral squamous cell carcinoma. Mol Carcinog. 2019;58(10):1783–1794. doi:10.1002/mc.2306531206208
   PubMed Web of Science ®Google Scholar
• Wang YF, Li BW, Sun S, et al. Circular RNA expression in oral squamous cell carcinoma. Front Oncol. 2018;8:398. doi:10.3389/fonc.2018.0039830349810
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi:10.1016/s0092-8674(04)00045-514744438
   PubMed Web of Science ®Google Scholar
• Li T, Li M, Xu C, et al. miR‑146a regulates the function of Th17 cell differentiation to modulate cervical cancer cell growth and apoptosis through NF‑κB signaling by targeting TRAF6. Oncol Rep. 2019;41(5):2897–2908. doi:10.3892/or.2019.704630864722
   PubMed Web of Science ®Google Scholar
• Xu Q, Zhu Q, Zhou Z, et al. MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1. Biomed Pharmacother. 2018;103:645–652. doi:10.1016/j.biopha.2018.04.03729679906
   PubMed Web of Science ®Google Scholar
• Hou G, Xu W, Jin Y, Wu J, Pan Y, Zhou F. MiRNA-217 accelerates the proliferation and migration of bladder cancer via inhibiting KMT2D. Biochem Biophys Res Commun. 2019;519(4):747–753. doi:10.1016/j.bbrc.2019.09.02931547991
   PubMed Web of Science ®Google Scholar
• Zha JF, Chen DX. MiR-655-3p inhibited proliferation and migration of ovarian cancer cells by targeting RAB1A. Eur Rev Med Pharmacol Sci. 2019;23(9):3627–3634.31114987
   PubMed Web of Science ®Google Scholar
• Wang N, Cao QX, Tian J. Circular RNA MTO1 inhibits the proliferation and invasion of ovarian cancer cells through the miR-182-5p/KLF15 axis. Int J oncol. 2020;29:963689720943613.
   Google Scholar
• Mao Y, Lv M, Cao W, et al. Circular RNA 000554 represses epithelial-mesenchymal transition in breast cancer by regulating microRNA-182/ZFP36 axis. FASEB J. 2020;34(9):11405–11420. doi:10.1096/fj.201903047R32729957
   PubMed Web of Science ®Google Scholar
• Liang L, Li L. Down-regulation of circNRIP1 promotes the apoptosis and inhibits the migration and invasion of gastric cancer cells by miR-182/ROCK1 axis. Onco Targets Ther. 2020;13:6279–6288. doi:10.2147/OTT.S22163332636647
   PubMed Web of Science ®Google Scholar
• Wang L, Jiang H, Li W, et al. Overexpression of TP53 mutation-associated microRNA-182 promotes tumor cell proliferation and migration in head and neck squamous cell carcinoma. Arch Oral Biol. 2017;73:105–112. doi:10.1016/j.archoralbio.2016.09.01227744260
   PubMed Web of Science ®Google Scholar
• Guo Y, Qiao X, Zhu L, Song R. MIR-182-5p modulates oral squamous cell carcinoma migration and invasion via targeting MTSS1 gene. Pathol Oncol Res. 2020;26(2):1007–1013. doi:10.1007/s12253-019-00647-830949866
   PubMed Web of Science ®Google Scholar
• Li N, Nan CC, Zhong XY, et al. miR-182-5p promotes growth in oral squamous cell carcinoma by inhibiting CAMK2N1. Cell Physiol Biochem. 2018;49(4):1329–1341. doi:10.1159/00049341130205384
   PubMedGoogle Scholar
• Zhang X, Guo Y, Xu X, et al. miR-146a promotes Borna disease virus 1 replication through IRAK1/TRAF6/NF-κB signaling pathway. Virus Res. 2019;271:197671. doi:10.1016/j.virusres.2019.19767131330207
   PubMed Web of Science ®Google Scholar
• Wei J, Yuan Y, Jin C, et al. The ubiquitin ligase TRAF6 negatively regulates the JAK-STAT signaling pathway by binding to STAT3 and mediating its ubiquitination. PLoS One. 2012;7(11):e49567. doi:10.1371/journal.pone.004956723185365
   PubMed Web of Science ®Google Scholar
• Hu Q, Song J, Ding B, Cui Y, Liang J, Han S. miR-146a promotes cervical cancer cell viability via targeting IRAK1 and TRAF6. Oncol Rep. 2018;39(6):3015–3024. doi:10.3892/or.2018.639129693168
   PubMed Web of Science ®Google Scholar
• Wu H, Lu XX, Wang JR, et al. TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation. Autophagy. 2019;15(9):1506–1522. doi:10.1080/15548627.2019.158625030806153
   PubMed Web of Science ®Google Scholar
• Hung PS, Liu CJ, Chou CS, et al. miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes. PLoS One. 2013;8(11):e79926. doi:10.1371/journal.pone.007992624302991
   PubMed Web of Science ®Google Scholar
• Min SK, Jung SY, Kang HK, et al. Functional diversity of miR-146a-5p and TRAF6 in normal and oral cancer cells. Int J Oncol. 2017;51(5):1541–1552. doi:10.3892/ijo.2017.412429048658
   PubMed Web of Science ®Google Scholar
• Piao HY, Guo S, Wang Y, Zhang J. Exosomal long non-coding RNA CEBPA-AS1 inhibits tumor apoptosis and functions as a non-invasive biomarker for diagnosis of gastric cancer. OncoTargets Therapy. 2020;13:1365–1374. doi:10.2147/OTT.S23870632110038
   PubMed Web of Science ®Google Scholar
• Militello G, Weirick T, John D, Döring C, Dimmeler S, Uchida S. Screening and validation of lncRNAs and circRNAs as miRNA sponges. Brief Bioinform. 2017;18(5):780–788. doi:10.1093/bib/bbw05327373735
   PubMed Web of Science ®Google Scholar
• Yang C, Wei Y, Yu L, Xiao Y. Identification of altered circular RNA expression in serum exosomes from patients with papillary thyroid carcinoma by high-throughput sequencing. Med Sci Monit. 2019;25:2785–2791. doi:10.12659/MSM.91565830988274
   PubMed Web of Science ®Google Scholar
• Qiu X, Ke X, Ma H, et al. Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing. J Cell Biochem. 2019;120(3):4102–4112. doi:10.1002/jcb.2769530269358
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453–461. doi:10.1038/nbt.289024811520
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388. doi:10.1038/nature1199323446346
   PubMed Web of Science ®Google Scholar
• Zhong Y, Du Y, Yang X, et al. Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer. 2018;17(1):79. doi:10.1186/s12943-018-0827-829626935
   PubMed Web of Science ®Google Scholar
• Wu YH, Wu WS, Liu LC, et al. Bortezomib enhances radiosensitivity in oral cancer through inducing autophagy-mediated TRAF6 oncoprotein degradation. J Exp Clin Cancer Res. 2018;37(1):91. doi:10.1186/s13046-018-0760-029703234
   PubMed Web of Science ®Google Scholar
• Fanale D, Taverna S, Russo A, Bazan V. Circular RNA in Exosomes. Adv Exp Med Biol. 2018;1087:109–117.30259361
   PubMed Web of Science ®Google Scholar
• Hou J, Jiang W, Zhu L, et al. Circular RNAs and exosomes in cancer: a mysterious connection. J Oncol. 2018;20(9):1109–1116.
   Google Scholar
• Zhang X, Wang S, Wang H, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Int J Oncol. 2019;18(1):20.
   Google Scholar
• Li Z, Yanfang W, Li J, et al. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer. Cancer Lett. 2018;432:237–250.29709702
   PubMed Web of Science ®Google Scholar
• Chen W, Quan Y, Fan S, et al. Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression. Cancer Lett. 2020;475:119–128.32014458
   PubMed Web of Science ®Google Scholar